10-year follow-up of adults screened for heart risk to create a Morocco-specific heart risk score
Official title: Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the "All With Heart" Association - Development of a Morocco-Specific Risk Score
Run by Moroccan Society of Cardiology · NCT07294937 · Data updated 2026-11-12
This project will try to see if information from people screened 10 years ago can be used to build a heart disease risk score tailored for Moroccan adults age 40 and older.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Moroccan Society of Cardiology Academic / other |
| Locations | 2 sites (Casablanca and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | March 2026 |
| Study ends | October 2026 |
| Registry record updated | December 19, 2025 |
| Trial ID | NCT07294937 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Moroccan adults who took part in the "All with heart" screening in Greater Casablanca between 2010 and 2012 and can provide written consent and be reached by phone, WhatsApp, or SMS.
✕Probably not a fit
People who cannot be reached, who moved away, who died from non-cardiovascular causes, or non-Moroccan participants are unlikely to benefit from this follow-up effort.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will re-contact more than 10,000 adults who participated in a 2010–2012 cardiovascular screening in Greater Casablanca to document cardiovascular deaths, heart attacks, and strokes using phone calls, WhatsApp, or SMS. Follow-up outcomes will be combined with baseline screening data to perform survival analysis and multivariable logistic regression. The team will use those results to develop and internally validate a predictive risk model specific to the Moroccan population. The project is coordinated by the Moroccan Society of Cardiology with clinical sites in Casablanca and Rabat and requires written informed consent for participation.
Why it matters
Potential benefit: If successful, the resulting Morocco-specific risk score could give clinicians a more accurate way to identify people at high risk of heart attack or stroke and target prevention locally.
How similar studies have gone: Long-term cohort studies and regional risk scores (for example Framingham or SCORE adaptations) have successfully predicted cardiovascular risk elsewhere, but a Morocco-specific model is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 40 years or older at the time of the initial screening (2010-2012). * Individuals who participated in the cardiovascular risk screening campaign conducted by the "All with heart" Association between 2010 and 2012 in the Greater Casablanca region. * Moroccan nationality. * Participants or family members who provide written informed consent for participation in the 10-year follow-up study. Exclusion Criteria: * Individuals who refuse to participate in the follow-up study. * Participants who have moved and cannot be reached by phone, WhatsApp, or SMS. * Participants who died from non-cardiovascular causes. * Non-Moroccan participants.
Where it's running
-
Moroccan Society of Cardiology
Casablanca, Morocco Recruiting -
Cardiology Centre, Mohammed V Military Hospital, Rabat, Morocco
Rabat, Morocco Recruiting
Study contacts
- Study coordinator: Najat MOUINE, Professor of Cardiology
- Email: mouine2@yahoo.fr
- Phone: +212661202733
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Colchicine to see if it reduces coronary artery inflammation in people with HIV
This study tests whether low-dose colchicine can lower inflammation in the coronary arteries of people with HIV who are at high heart-disease risk, compared with a placebo.
-
Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation
This trial tests the Laplace TTVR System to see if it safely and effectively treats adults with severe tricuspid regurgitation.
-
A lifetime registry and imaging database for people with heart, kidney, and metabolic conditions
This project will see if creating a long-term clinical and imaging database for adults with heart, kidney, or metabolic conditions can improve prediction of outcomes and guide care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.